Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations. | J Allergy Clin Immunol Pract | 2023 | 36948491 | PubTator, text mining | PubMed |
| The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. | Cell Mol Immunol | 2023 | 36928371 | PubTator, text mining | PubMed |
| The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review. | Ann Allergy Asthma Immunol | 2023 | 36924937 | PubTator, text mining | PubMed |
| Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies. | Front Immunol | 2023 | 36923402 | PubTator, text mining | PubMed |
| Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. | J Transl Med | 2023 | 36922828 | PubTator, text mining | PubMed |
| Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. | Mol Ther Oncolytics | 2023 | 36915911 | PubTator, text mining | PubMed |
| Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice. | J Vis Exp | 2023 | 36912520 | PubTator, text mining | PubMed |
| Extracellular Vesicles (EVs) as Crucial Mediators of Cell-Cell Interaction in Asthma. | Int J Mol Sci | 2023 | 36902079 | PubTator, text mining | PubMed |
| CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression. | Cancers (Basel) | 2023 | 36900205 | PubTator, text mining | PubMed |
| Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice. | J Immunother Cancer | 2023 | 36898734 | PubTator, text mining | PubMed |
| Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings. | Immunoinformatics (Amst) | 2023 | 36875891 | PubTator, text mining | PubMed |
| Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosis. | Front Immunol | 2023 | 36875109 | PubTator, text mining | PubMed |
| Immunotherapy associated central nervous system complications in primary brain tumors. | Front Oncol | 2023 | 36874119 | PubTator, text mining | PubMed |
| The immunotherapy advancement targeting malignant blastomas in early childhood. | Front Oncol | 2023 | 36874100 | PubTator, text mining | PubMed |
| A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis. | Res Pharm Sci | 2023 | 36873271 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors. | Front Immunol | 2023 | 36860862 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| CAR-T Therapies in Solid Tumors: Opportunities and Challenges. | Curr Oncol Rep | 2023 | 36853475 | PubTator, text mining | PubMed |
| Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies. | Viruses | 2023 | 36851761 | PubTator, text mining | PubMed |
| Targeting Interleukin 13 for the Treatment of Atopic Dermatitis. | Pharmaceutics | 2023 | 36839890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=24